Perhaps one of the least understood changes are the proposed TGA schedule 3 classification for cbd which appears to provide a much more accessible product with real and improved health benefits.
This is not strictly true as many studies in the field have already established the milligram dosage required for such therapeutic benefits to be realised needs to be between 300mg and 1500mg. The TGA otc cbd product dosage access is far short of this at 60mg -150mg at this stage.
This, in my own opinion, has the potential to leave the market unimpressed regarding the available otc product and its health benefit potential, damaging both the perceived health outcomes achievable as well as generated revenues.
This, to my mind, highlights the need for greater product education and training for prescribing GPs' in line with the previous post.
just sayin
- Forums
- ASX - By Stock
- Dream big with Zelira
Perhaps one of the least understood changes are the proposed TGA...
-
- There are more pages in this discussion • 1,138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
70.0¢ |
Change
-0.030(4.11%) |
Mkt cap ! $7.943M |
Open | High | Low | Value | Volume |
73.0¢ | 73.0¢ | 70.0¢ | $1.785K | 2.485K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2160 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 733 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2160 | 0.700 |
2 | 16175 | 0.680 |
1 | 1000 | 0.670 |
1 | 5000 | 0.600 |
1 | 1686 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.760 | 733 | 1 |
0.770 | 474 | 1 |
0.800 | 710 | 1 |
0.810 | 1045 | 2 |
0.860 | 362 | 3 |
Last trade - 14.24pm 29/03/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |